Japanese Encephalitis Vaccine (JEV)
DLA Troop Support · DLA TROOP SUPPORT
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation SPE2DP-26-R-0001 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV) - Synopsis Solicitation: SPE2DP-26-R-0001 Item: Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV) NSN: 6505-01-607-7018 Description: The Defense Logistics Agency Troop Support has a requirement for the supply of Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV). JEV shall be made in accordance with MPID Number 5 dated 23 July 2024, which is attached to this notice. The Solicitation will be issued under author… (show all)
ity 10 U.S.C. � 3204(a)(1), implemented by FAR 6.302-1 (�Only one responsible source and no other supplies or services will satisfy agency requirements�). The Government intends to use Part 12 for this acquisition � per FAR 10.002(d)(2). The proposed contract will be a firm-fixed price, indefinite delivery, indefinite quantity type contract. The contract will consist of an eighteen (18) month base term. The minimum quantity is 277,760 each (EA). The estimated quantity is 277,760 each. The maximum quantity is 394,240 each. Inspection/Acceptance at Destination FOB Destination Delivery Destination: DODAAC: SV3100 DLA Distribution Susquehanna U Avenue, Bldg. 89, Door 6 New Cumberland, PA 17070 Attn: Jim Earp Production Lead Time is 120 days after issuance date of the delivery order (DD1155). All responsible sources may submit a proposal and shall be considered by the Agency. The successful contractor shall have FDA approval to sell JEV prior to the Solicitation�s closing date and time. **************************************************************************** IMPORTANT NOTICES Availability of solicitations, FAR 5.102(d) applies, as our office no longer issues solicitations or amendments in paper form. Offeror should register to receive notification of this solicitation or solicitation amendments. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Detailed system requirements and instructions for registration can be found on the DLA DIBBS Home Page accessed on https://www.dibbs.bsm.dla.mil/. Once the solicitation is posted, it will be available for viewing on DIBBS. From the DIBBS homepage, select "Solicitations" from the top bar to search for the solicitation. DIBBS Help can be accessed from the DIBBS homepage. Interested parties are further advised to set up automated notifications of solicitation changes through this website. Solicitation SPE2DP-23-R-0002 is expected to be issued on or around May 2024. ****************************************************************************** Contracting Office Address: Defense Logistics Agency, Acquisition Management, DLA Troop Support - Medical, 700 Robbins Avenue, Philadelphia, PA, 19111-5092, UNITED STATES Point of Contact(s): Alec Deichman, Contracting Specialist, Phone: 445-737-5743 , Email: Alec.Deichman@dla.mil Jessica De La Hoz, Contracting Officer, Phone: 445-737-3623, Email: Jessica.DeLaHoz@dla.mil
Who won similar work
6 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 325414.
| Winner | Awards | Value | Last |
|---|---|---|---|
| SEQIRUS USA INC | 3 | $25.1M | Feb 9, 2026 |
| SANOFI PASTEUR INC. | 1 | $25.1M | Apr 25, 2025 |
| SANOFI VACCINES US INC. | 1 | $13.1M | Feb 9, 2026 |
| DMS PHARMACEUTICAL GROUP INC | 1 | $81K | Feb 26, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Feb 26, 2026DMS PHARMACEUTICAL GROUP INC$81K65--MENINGOCOCCAL GROUP
- Feb 9, 2026SEQIRUS USA INC$2.3M65--INFLUENZA VIRUS VAC
- Feb 9, 2026SANOFI VACCINES US INC.$13.1M65--INFLUENZA VIRUS VAC
- Feb 6, 2026SEQIRUS USA INC$16.0M65--INFLUENZA VIRUS VAC
- Apr 25, 2025SEQIRUS USA INC$6.9MInjectable Egg-Free Influenza Vaccine
- Apr 25, 2025SANOFI PASTEUR INC.$25.1MInjectable Influenza Vaccine
Competitive landscape
For the 4 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Defense Logistics Agency since 2024 (0 filings)
- 0 of their lobbyists list a past Defense Logistics Agency job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 32 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.